New York City, NY -- (SBWIRE) -- 10/25/2013 -- StockMarketIntel.com issues a special report on the following stocks: THEDIRECTORY.COM INC (OTCMKTS:SEEK), Boston Scientific Corporation (NYSE:BSX), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Celsion Corporation (NASDAQ:CLSN)
THEDIRECTORY.COM INC (OTCMKTS:SEEK) declined -13.51%, trading on 203.43 million shares, to end the trade at $0.0032. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.0001 and was moved to the maximum level of $0.0044. The stock changed hands in a range of $0.0025 to $0.0039, bringing its market capitalization to about $9.23 million.
Has SEEK Found The Bottom and Ready To Move Up? Find Out Here
Boston Scientific Corporation (NYSE:BSX) declined -6.10%, to complete the trading session at $11.54, with a total volume of 44.74 million shares. The stock, on average, trades on a volume of 12.56 million shares. In the past 52 weeks, the share price has not declined below $5.04 and above $12.48. It floated in a range of $11.16 to $12.07 during the last trading session, with a beta value of 1.30. Its market capitalization now moved to about $15.50 billion. Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2011, its products were offered for sale by seven core businesses: Interventional Cardiology, CRM, Endoscopy, Peripheral Interventions, Urology/Women’s Health, Neuromodulation, and Electrophysiology.
Has BSX Found The Bottom And Ready To Gain Momentum? Find Out Here
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) recorded a fall of -.256% and was in a range of $9.55-$10.02 before closing at $9.68. The share price hit its 52-week low of $1.77 and $11.49 was the best price. The stock completed the day with a total volume of 10.27 million shares, versus an average volume of 10.74 million shares. Himax Technologies, Inc. operates as an IC design house with LCD manufacturing capability. The Company focuses on display IC products for display device and offers LCD technical consulting to customers to provide them with value-added technical support and integrated solutions.
Why Should Investors Buy HIMX After the Recent Fall? Just Go Here and Find Out
Celsion Corporation (NASDAQ:CLSN) added 2.56% yesterday, bringing its market capitalization around $73.39million. The total number of shares that changed hands during the session was 5.44million shares, as compared to average trading volume of 1.26 million shares. The share price, after opening at $1.25, made a high of $1.31and hovered above $1.18 to end the day at $1.20. Celsion Corporation is an oncology drug development company focused on the development of treatments for those suffering with difficult to treat forms of cancer. As of December 31, 2011, the Company's product ThermoDox is being evaluated in a Phase III clinical trial for primary liver cancer (the HEAT study), a Phase II clinical trial for colorectal liver metastasis (CRLM) and a Phase II clinical trial for recurrent chest wall breast cancer.
What was the Moving Force behind CLSN on Bullish Run? Read This Research Report
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)